This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Swiss spec pharma ObsEva completes $90mm IPO on Nasdaq
28 Mar 2017
Three months after an October 2016 announcement of its intent to go public in the US, Swiss women’s health company ObsEva SA (small-molecule therapeutics for serious conditions in reproductive health and pregnancy) netted $90mm in an IPO on Nasdaq of 6.45mm shares at $15, the mid-point of its anticipated range.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?